Affiliation:
1. Arthritis and Immunology Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA;
2. Dept. of Medicine, University of Oklahoma Health Sciences Center;
3. Dept. of Veterans Affairs Medical Center, Oklahoma City; and
4. University of Central Oklahoma, Edmond, OK, USA
Abstract
Sjögren’s syndrome is a common autoimmune rheumatic disease. The most common symptoms of Sjögren’s syndrome are extreme tiredness, along with dry eyes (keratoconjunctivitis sicca) and dry mouth (xerostomia). Saliva plays an essential role in numerous functions of the mouth. Xerostomia can be caused by medications, chronic diseases like Sjögren’s syndrome, and medical treatments, such as radiation therapy and bone marrow transplant. Xerostomia can eventually lead to difficulty in swallowing, severe and progressive tooth decay, or oral infections. Despite having excellent oral hygiene, individuals with Sjögren’s syndrome have elevated levels of dental caries, along with the loss of many teeth, early in the disease. Sjögren’s syndrome alters the protein profile and brings about a change in the composition of saliva. There is an increase in the levels of lactoferrin, β2-microglobulin, sodium, lysozyme C, and cystatin C, and a decrease in salivary amylase and carbonic anhydrase. Up to 90% of individuals with Sjögren’s syndrome have antibodies targeting the Ro 60 and La autoantigens. Natural aging, regardless of Sjögren’s syndrome, is also another factor that brings about a significant change in the composition of saliva. The most prevailing cause of xerostomia in elderly persons is the use of anticholinergic medications. Currently, there is no cure for Sjögren’s syndrome, and treatment is mainly palliative.
Cited by
146 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献